Molecular diagnosis of polycystic ovary syndrome in obese and non-obese women by targeted plasma miRNA profiling.

Autor: Romero-Ruiz A; Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Spain.; Department of Cell Biology, Physiology and Immunology, University of Córdoba, Córdoba, Spain.; Hospital Universitario Reina Sofia, Córdoba, Spain., Pineda B; Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Spain.; Hospital Universitario Reina Sofia, Córdoba, Spain., Ovelleiro D; Area of Cellular Biology, Department of Experimental Biology, University of Jaen, Jaen, Spain., Perdices-Lopez C; Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Spain.; Department of Cell Biology, Physiology and Immunology, University of Córdoba, Córdoba, Spain.; CIBER Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III, Córdoba, Spain., Torres E; Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Spain.; Department of Cell Biology, Physiology and Immunology, University of Córdoba, Córdoba, Spain.; Hospital Universitario Reina Sofia, Córdoba, Spain., Vazquez MJ; Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Spain.; Department of Cell Biology, Physiology and Immunology, University of Córdoba, Córdoba, Spain.; Hospital Universitario Reina Sofia, Córdoba, Spain., Guler I; Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Spain., Jiménez Á; Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Spain., Pineda R; Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Spain.; Department of Cell Biology, Physiology and Immunology, University of Córdoba, Córdoba, Spain., Persano M; Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Spain.; Hospital Universitario Reina Sofia, Córdoba, Spain., Romero-Baldonado C; Hospital Universitario Reina Sofia, Córdoba, Spain., Arjona JE; Hospital Universitario Reina Sofia, Córdoba, Spain., Lorente J; Hospital Universitario Reina Sofia, Córdoba, Spain., Muñoz C; Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Spain.; Hospital Universitario Reina Sofia, Córdoba, Spain., Paz E; Canvax Biotech, Córdoba, Spain., Garcia-Maceira FI; Canvax Biotech, Córdoba, Spain., Arjona-Sánchez Á; Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Spain.; Hospital Universitario Reina Sofia, Córdoba, Spain., Tena-Sempere M; Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Spain.; Department of Cell Biology, Physiology and Immunology, University of Córdoba, Córdoba, Spain.; Hospital Universitario Reina Sofia, Córdoba, Spain.; CIBER Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III, Córdoba, Spain.; Institute of Biomedicine, University of Turku, Turku, Finland.

Publikováno v: European journal of endocrinology [Eur J Endocrinol] 2021 Oct 08; Vol. 185 (5), pp. 637-652. Date of Electronic Publication: 2021 Oct 08.

Prediabetes diagnosis criteria, type 2 diabetes risk and dietary modulation: The CORDIOPREV study.

Autor: Roncero-Ramos I; Lipids and Atherosclerosis Unit, Department of Internal Medicine, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Cordoba, Spain; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Cordoba, Spain., Alcala-Diaz JF; Lipids and Atherosclerosis Unit, Department of Internal Medicine, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Cordoba, Spain; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Cordoba, Spain., Rangel-Zuñiga OA; Lipids and Atherosclerosis Unit, Department of Internal Medicine, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Cordoba, Spain; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Cordoba, Spain., Gomez-Delgado F; Lipids and Atherosclerosis Unit, Department of Internal Medicine, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Cordoba, Spain; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Cordoba, Spain., Jimenez-Lucena R; Lipids and Atherosclerosis Unit, Department of Internal Medicine, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Cordoba, Spain; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Cordoba, Spain., García-Rios A; Lipids and Atherosclerosis Unit, Department of Internal Medicine, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Cordoba, Spain; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Cordoba, Spain., Vals-Delgado C; Lipids and Atherosclerosis Unit, Department of Internal Medicine, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Cordoba, Spain; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Cordoba, Spain., Romero-Baldonado C; Biochemical Laboratory, Reina Sofia University Hospital, Córdoba, Spain., Luque RM; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Cordoba, Spain; Department of Cell Biology, Physiology, and Immunology, University of Córdoba, Reina Sofía University Hospital, Maimonides Biomedical Research Institute of Córdoba (IMIBIC), Córdoba, Spain., Ordovas JM; Nutrition and Genomics Laboratory, J.M.-US Department of Agriculture Human Nutrition Research Center on Aging at Tufts University, Boston, Massachusetts, Spain; IMDEA Alimentacion, Madrid, Spain; CNIC, Madrid, Spain., Perez-Martinez P; Lipids and Atherosclerosis Unit, Department of Internal Medicine, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Cordoba, Spain; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Cordoba, Spain., Camargo A; Lipids and Atherosclerosis Unit, Department of Internal Medicine, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Cordoba, Spain; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Cordoba, Spain., Lopez-Miranda J; Lipids and Atherosclerosis Unit, Department of Internal Medicine, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Cordoba, Spain; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Cordoba, Spain. Electronic address: jlopezmir@uco.es.

Publikováno v: Clinical nutrition (Edinburgh, Scotland) [Clin Nutr] 2020 Feb; Vol. 39 (2), pp. 492-500. Date of Electronic Publication: 2019 Feb 21.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Prospective multicentre study in intensive care units in five cities from the Kingdom of Saudi Arabia: Impact of the International Nosocomial Infection Control Consortium (INICC) multidimensional approach on rates of central line-associated bloodstream infection.

Autor: Al-Abdely HM; General Directorate of Prevention and Infection Control, Ministry of Health, Riyadh, Saudi Arabia.; Assir Central Hospital, Assir, Saudi Arabia., Alshehri AD; General Directorate of Prevention and Infection Control, Ministry of Health, Riyadh, Saudi Arabia., Rosenthal VD; International Nosocomial Infection Control Consortium (INICC), Buenos Aires, Argentina., Mohammed YK; General Directorate of Prevention and Infection Control, Ministry of Health, Riyadh, Saudi Arabia.; Assir Central Hospital, Assir, Saudi Arabia., Banjar W; General Directorate of Prevention and Infection Control, Ministry of Health, Riyadh, Saudi Arabia., Orellano PW; International Nosocomial Infection Control Consortium (INICC), Buenos Aires, Argentina.; Universidad Tecnológica Nacional, Facultad Regional San Nicolás and Consejo Nacional de Investigaciones Científicas y Técnicas, San Nicolás, Argentina., Assiri AM; General Directorate of Prevention and Infection Control, Ministry of Health, Riyadh, Saudi Arabia., Kader NMA; King Khalid Hospital, Najran, Saudi Arabia., Enizy HAA; King Khalid Hospital, Tabuk, Saudi Arabia., Mohammed DA; King Abdulaziz Specialist Hospital, Taif, Saudi Arabia., Al-Awadi DK; Hera General Hospital, Makkah, Saudi Arabia., Cabato AF; Assir Central Hospital, Assir, Saudi Arabia., Wasbourne M; General Directorate of Prevention and Infection Control, Ministry of Health, Riyadh, Saudi Arabia., Saliya R; General Directorate of Prevention and Infection Control, Ministry of Health, Riyadh, Saudi Arabia., Aromin RG; King Khalid Hospital, Najran, Saudi Arabia., Ubalde EB; King Khalid Hospital, Najran, Saudi Arabia., Diab HH; King Khalid Hospital, Najran, Saudi Arabia., Alkamaly MA; King Khalid Hospital, Najran, Saudi Arabia., Alanazi NM; King Khalid Hospital, Najran, Saudi Arabia., Hassan Assiry IY; King Khalid Hospital, Najran, Saudi Arabia., Molano AM; King Khalid Hospital, Najran, Saudi Arabia., Flores Baldonado C; King Khalid Hospital, Najran, Saudi Arabia., Al-Azhary M; King Khalid Hospital, Najran, Saudi Arabia.; Assir Central Hospital, Assir, Saudi Arabia., Al Atawi S; King Khalid Hospital, Tabuk, Saudi Arabia., Molano AM; King Khalid Hospital, Tabuk, Saudi Arabia., Al Adwani FM; King Khalid Hospital, Tabuk, Saudi Arabia., Casuyon Pahilanga AM; King Khalid Hospital, Tabuk, Saudi Arabia., Nakhla R; King Khalid Hospital, Tabuk, Saudi Arabia., Al Adwani FM; King Khalid Hospital, Tabuk, Saudi Arabia., Nair DS; King Abdulaziz Specialist Hospital, Taif, Saudi Arabia., Sindayen G; King Abdulaziz Specialist Hospital, Taif, Saudi Arabia., Malificio AA; King Abdulaziz Specialist Hospital, Taif, Saudi Arabia., Helali NJ; King Abdulaziz Specialist Hospital, Taif, Saudi Arabia., Al Dossari HB; King Abdulaziz Specialist Hospital, Taif, Saudi Arabia., Kelany A; King Abdulaziz Specialist Hospital, Taif, Saudi Arabia., Algethami AG; King Abdulaziz Specialist Hospital, Taif, Saudi Arabia., Yanne L; King Abdulaziz Specialist Hospital, Taif, Saudi Arabia., Tan A; King Abdulaziz Specialist Hospital, Taif, Saudi Arabia., Babu S; King Abdulaziz Specialist Hospital, Taif, Saudi Arabia., Abduljabbar SM; King Abdulaziz Specialist Hospital, Taif, Saudi Arabia., Bukhari SZ; Hera General Hospital, Makkah, Saudi Arabia., Basri RH; Hera General Hospital, Makkah, Saudi Arabia., Mushtaq JJ; Hera General Hospital, Makkah, Saudi Arabia., Rushdi H; Hera General Hospital, Makkah, Saudi Arabia., Turkistani AA; Hera General Hospital, Makkah, Saudi Arabia., Gonzales Celiz JM; Assir Central Hospital, Assir, Saudi Arabia., Al Raey MA; Assir Central Hospital, Assir, Saudi Arabia., Al-Zaydani Asiri IA; Assir Central Hospital, Assir, Saudi Arabia., Aldarani SA; Assir Central Hospital, Assir, Saudi Arabia., Laungayan Cortez E; Assir Central Hospital, Assir, Saudi Arabia., Demaisip NL; Assir Central Hospital, Assir, Saudi Arabia., Aziz MR; Assir Central Hospital, Assir, Saudi Arabia., Omer Abdul Aziz A; Assir Central Hospital, Assir, Saudi Arabia., Al Manea B; Assir Central Hospital, Assir, Saudi Arabia., Samy E; Assir Central Hospital, Assir, Saudi Arabia., Al-Dalaton M; Assir Central Hospital, Assir, Saudi Arabia., Alaliany MJ; Assir Central Hospital, Assir, Saudi Arabia.

Publikováno v: Journal of infection prevention [J Infect Prev] 2017 Jan; Vol. 18 (1), pp. 25-34. Date of Electronic Publication: 2016 Oct 22.

Human umbilical cord mesenchymal stromal cell small extracellular vesicle transfer of microRNA-223-3p to lung epithelial cells attenuates inflammation in acute lung injury in mice.

Autor: Chen, Jie^1,2,3,4,5 (AUTHOR), Ma, Shiyang^1,2,3,4,5 (AUTHOR), Luo, Baihua⁶ (AUTHOR), Hao, Haojie⁷ (AUTHOR), Li, Yanqin⁸ (AUTHOR), Yang, Hang^1,2,3,4,5 (AUTHOR), Zhu, Fei^1,2,3,4,5 (AUTHOR), Zhang, Peipei^1,2,3,4,5 (AUTHOR), Niu, Ruichao^1,2,3,4,5,9 (AUTHOR) nrc226@163.com, Pan, Pinhua^1,2,3,4,5 (AUTHOR) pinhuapan668@csu.edu.cn

Publikováno v: Journal of Nanobiotechnology. 8/25/2023, Vol. 21 Issue 1, p1-18. 18p.